Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 16;5(1):e006276.
doi: 10.1136/bmjopen-2014-006276.

The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study

Affiliations

The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study

Hidetaka Hamasaki et al. BMJ Open. .

Abstract

Objectives: In spite of accumulating evidences suggesting an inverse association between insulin resistance and plasma B-type natriuretic peptide (BNP) levels, the effect of daily physical activity on plasma BNP in individuals with glucose intolerance remains unknown. We investigated the association of physical activity level (PAL) with plasma BNP in patients with impaired fasting glucose, impaired glucose tolerance and type 2 diabetes.

Design: Cross-sectional study.

Setting: Outpatients visiting the National Center for Global Health and Medicine Kohnodai Hospital.

Participants: A total of 60 patients with glucose intolerance who did not take any hypoglycaemic agents, cholesterol-lowering agents and antihypertensive agents were recruited. Patients who were diagnosed as having heart failure and renal impairment, engaged in sports-like exercise and resistance training were excluded.

Primary outcome measures: PAL was objectively measured by a triaxial accelerometer. The association between PAL and plasma BNP levels was assessed by multiple regression analysis.

Results: PAL was positively correlated with plasma BNP levels (r=0.296, p=0.021). PAL was still significantly correlated with plasma BNP levels after adjustment for age (β=0.290, p=0.014), and adjustment for age and body mass index (β=0.282, p=0.018). Plasma BNP levels were inversely correlated with serum insulin levels (r=-0.350, p=0.006) and homeostasis model assessment-estimated insulin resistance (HOMA-IR; r=-0.363, p=0.004). Serum insulin levels (mean±SD, 8.1±6.4 μU/mL) and HOMA-IR (2.4±1.9) in the high-BNP group were significantly lower than those (11.2±7.4 μU/mL and 3.7±3.0, respectively) in the low-BNP group.

Conclusions: Our findings propose the possibility that plasma BNP may be increased by daily physical activity and BNP is associated with insulin resistance.

Keywords: DIABETES & ENDOCRINOLOGY; PUBLIC HEALTH; SPORTS MEDICINE.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation of physical activity level and plasma BNP levels in 60 participants. r Indicates the correlation coefficient analysed by Spearman's rank correlation coefficient.
Figure 2
Figure 2
Serum insulin levels (A) and the homeostatic model assessment-estimated insulin resistance (HOMA-IR) (B) in the high-BNP group (n=30) and the low-BNP group (n=30). Data are mean values±SD. We divided participants into the high-BNP group (≧8.0 pg/mL) and the low-BNP group (<8.0 pg/mL) by the median values of BNP. Differences in serum insulin levels and HOMA-IR between the high-BNP group and the low-BNP group were analysed by the Mann-Whitney U test.
Figure 3
Figure 3
Serum insulin levels (A) and homeostatic model assessment-estimated insulin resistance (HOMA-IR) (B) in each plasma BNP quartiles. Q1 is the lowest quartile and Q4 is the highest quartile. Boxes indicate medians and quartiles; whiskers indicate the lowest and highest values. We found a significant influence of plasma BNP on both serum insulin (p=0.018 by the Kruskal-Wallis ANOVA) and HOMA-IR (p=0.018). The difference between Q1 and Q2–4 was statistically analysed by Scheffe's F Test.

Similar articles

Cited by

References

    1. Gardner DG, Chen S, Glenn DJ et al. . Molecular biology of the natriuretic peptide system: implications for physiology and hypertension. Hypertension 2007;49:419–26. 10.1161/01.HYP.0000258532.07418.fa - DOI - PubMed
    1. Maeda K, Tsutamoto T, Wada A et al. . High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1587–93. 10.1016/S0735-1097(00)00912-8 - DOI - PubMed
    1. Wang TJ, Larson MG, Levy D et al. . Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655–63. 10.1056/NEJMoa031994 - DOI - PubMed
    1. Alehagen U, Lindstedt G, Levin LA et al. . Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population. Int J Cardiol 2005;100:125–33. 10.1016/j.ijcard.2004.10.006 - DOI - PubMed
    1. Kroon MH, van den Hurk K, Alssema M et al. . Prospective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: an 8-year follow-up of the Hoorn Study. Diabetes Care 2012;35:2510–14. 10.2337/dc11-1959 - DOI - PMC - PubMed

Publication types